Assessing XtalPi Holdings (SEHK:2228) Valuation After New CFO With Global Healthcare Capital Markets Experience

Simply Wall St.03-25

AdvertisementNew CFO appointment puts financial leadership in focus XtalPi Holdings (SEHK:2228) has appointed Mr. Zhou Feiran as chief financial officer, effective 10 March 2026. The move is drawing ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2622159040?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","is_english":true,"pubTime":"2026-03-25 04:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2622159040","market":"hk","top_or_hot":-1,"title":"Assessing XtalPi Holdings (SEHK:2228) Valuation After New CFO With Global Healthcare Capital Markets Experience","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementNew CFO appointment puts financial leadership in focus XtalPi Holdings (SEHK:2228) has appointed Mr. Zhou Feiran as chief financial officer, effective 10 March 2026. The move is drawing ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2228/xtalpi-holdings-shares/news/assessing-xtalpi-holdings-sehk2228-valuation-after-new-cfo-w\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Assessing XtalPi Holdings (SEHK:2228) Valuation After New CFO With Global Healthcare Capital Markets Experience</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAssessing XtalPi Holdings (SEHK:2228) Valuation After New CFO With Global Healthcare Capital Markets Experience\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-25 04:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2228/xtalpi-holdings-shares/news/assessing-xtalpi-holdings-sehk2228-valuation-after-new-cfo-w><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AdvertisementNew CFO appointment puts financial leadership in focus XtalPi Holdings (SEHK:2228) has appointed Mr. Zhou Feiran as chief financial officer, effective 10 March 2026. The move is drawing ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2228/xtalpi-holdings-shares/news/assessing-xtalpi-holdings-sehk2228-valuation-after-new-cfo-w\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1141","symbol_name":"生命科学工具和服务","start_time":0,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2228/xtalpi-holdings-shares/news/assessing-xtalpi-holdings-sehk2228-valuation-after-new-cfo-w","article_id":"2622159040","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2228/xtalpi-holdings-shares/news/assessing-xtalpi-holdings-sehk2228-valuation-after-new-cfo-w","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2622159040","pubTimestamp":1774383194,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"New CFO appointment puts financial leadership in focus\nXtalPi Holdings (SEHK:2228) has appointed Mr. Zhou Feiran as chief financial officer, effective 10 March 2026. The move is drawing investor attention to the company’s capital markets expertise and future funding and transaction decisions.\nSee our latest analysis for XtalPi Holdings.\nAt a share price of HK$9.09, XtalPi Holdings has seen a 1-day share price return of 1.91% but a 30-day share price return decline of 19.20%. The 1-year total...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1141":"生命科学工具和服务","BK1617":"AI医疗","XBI":"SPDR S&P Biotech ETF","DCF":"Dreyfus Alcentra Global Credit Income 2024 Target Term Fund, Inc","HCCCU":"Healthcare Capital Corp.","BK4588":"碎股","BK4585":"ETF&股票定投概念","02228":"晶泰控股","LABU":"三倍做多标普生物-Direxion","XLV":"健康照护类股ETF-SPDR","BK4581":"高盛持仓"},"translate_title":"在具有全球医疗保健资本市场经验的新任首席财务官任命后评估XtalPi Holdings(SEHK：2228)的估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XBI":0.6,"LABU":0.6,"XLV":1.5,"02228":0.9,"DCF":1,"HCCCU":1.5},"content_text":"AdvertisementNew CFO appointment puts financial leadership in focus XtalPi Holdings (SEHK:2228) has appointed Mr. Zhou Feiran as chief financial officer, effective 10 March 2026. The move is drawing investor attention to the company’s capital markets expertise and future funding and transaction decisions. See our latest analysis for XtalPi Holdings. At a share price of HK$9.09, XtalPi Holdings has seen a 1-day share price return of 1.91% but a 30-day share price return decline of 19.20%. The 1-year total shareholder return of 58.92% still points to strong longer term momentum as investors reassess the company around recent leadership changes. If this CFO appointment has you thinking more broadly about where capital could go next in healthcare AI, it is worth scanning 127 healthcare AI stocks for other potential ideas. With shares down 19.20% over the past month and a 1-year total return of 58.92%, investors now have to ask whether XtalPi is trading at a discount after recent volatility, or whether the market is already pricing in future growth. Preferred Price-to-Book of 4.9x: Is it justified? At HK$9.09 per share and a P/B of 4.9x, XtalPi Holdings trades at a richer level than many peers, which raises questions about what the market is paying up for. The P/B ratio compares the company’s market value to its book value. A higher multiple often reflects expectations around future growth or valuable intangibles that do not fully sit on the balance sheet. For XtalPi Holdings, this sits alongside an unprofitable profile today and an SWS DCF value estimate of HK$4.96, which implies the market price is comfortably above that model’s output. Relative to the Asian Life Sciences industry average P/B of 2.3x and a broader peer average of 2.6x, XtalPi Holdings is priced at almost double those levels. That gap suggests investors are willing to ascribe a premium to its AI driven drug discovery and robotics businesses, despite current losses and a value score of 0 in the SWS framework. See what the numbers say about this price — find out in our valuation breakdown. Result: Price-to-book of 4.9x (OVERVALUED) However, you also need to weigh the HK$196.795m net loss and the reliance on revenue from outside Mainland China, which could expose the story to contract or funding setbacks. Find out about the key risks to this XtalPi Holdings narrative. Another angle: price target vs current price While the SWS DCF value sits at HK$4.96 compared with the HK$9.09 share price, the current analyst price target of HK$9.99 is only about 10% above where the stock trades today. That is not a huge gap. How much upside are you really paying for at this level? Look into how the SWS DCF model arrives at its fair value. 2228 Discounted Cash Flow as at Mar 2026Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out XtalPi Holdings for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 243 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity. Next Steps The mixed signals in this article might leave you undecided, so it makes sense to act quickly and assess the potential upside yourself by checking the 2 key rewards Looking for more investment ideas? If XtalPi has sharpened your thinking about risk, growth and price, do not stop here. Broader context from other stocks can often sharpen your next move.  Spot potential bargains early by scanning 243 high quality undervalued stocks, which combines appealing prices with stronger fundamentals than the market might be giving them credit for. Prioritise resilience by checking 274 resilient stocks with low risk scores so you are not caught off guard by companies with weaker risk profiles than you expected. Hunt for less crowded ideas through the screener containing 590 high quality undiscovered gems before attention and capital move on to the next set of opportunities.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"executive","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2622159040","isCrawlerRequest":true}